Checkpoint-inhibition in ovarian cancer: rising star or just a dream?

The introduction of checkpoint inhibitors revolutionized immuno-oncology. The efficacy of traditional immunotherapeutics, like vaccines and immunostimulants was very limited due to persistent immune-escape strategies of cancer cells. Checkpoint inhibitors target these escape mechanisms and re-direct...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gynecol Oncol
Main Authors: Pietzner, Klaus, Nasser, Sara, Alavi, Sara, Darb-Esfahani, Silvia, Passler, Mona, Muallem, Mustafa Zelal, Sehouli, Jalid
Formato: Artigo
Idioma:Inglês
Publicado em: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6189441/
https://ncbi.nlm.nih.gov/pubmed/30207101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2018.29.e93
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados